Stock Information
Arcutis Biotherapeutics Inc (ARQT)
Ticker Symbol: ARQT
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,303.61 mil
Piotroski score: 6
PE Ratio: N/A
EPS (TTM): -0.1325
Revenue (TTM): $2.93 M
Dividend Yield: N/A%
ROE: -10.26%
Latest News
-
Baron Health Care Fund Q4 2025 Recent Activity
Tue, Mar 3, 2026 10:36 AM
-
Arcutis Biotherapeutics Enrolls The First Participant In Phase 1a/1b Study (ARQ-234-131) To Evaluate Safety And Tolerability For Investigational Arq-234 In Healthy Volunteers And Adults With Moderate To Severe Atopic Dermatitis
Tue, Mar 3, 2026 9:08 AM
-
Arcutis Biotherapeutics shares are trading lower after Mizuho lowered its price target on the stock from $37 to $35.
Mon, Mar 2, 2026 12:23 PM
-
Mizuho Maintains Outperform on Arcutis Biotherapeutics, Lowers Price Target to $35
Mon, Mar 2, 2026 9:03 AM
-
Arcutis Biotherapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation
Fri, Feb 27, 2026 6:08 PM
-
Guggenheim Maintains Buy on Arcutis Biotherapeutics, Raises Price Target to $35
Fri, Feb 27, 2026 11:44 AM
-
Forecasting The Future: 4 Analyst Projections For Arcutis Biotherapeutics
Thu, Feb 26, 2026 2:00 PM
-
TD Cowen Maintains Buy on Arcutis Biotherapeutics, Raises Price Target to $35
Thu, Feb 26, 2026 1:41 PM
-
Arcutis Earnings: Zoryve Dominance And Pipeline Catalysts Drive The Bull Case
Thu, Feb 26, 2026 12:01 PM
-
HC Wainwright & Co. Maintains Buy on Arcutis Biotherapeutics, Raises Price Target to $34
Thu, Feb 26, 2026 10:17 AM
Key Financials
Financial data not available
